Members of EBAN, the European Business Angel Network, voted Sensius to be the winner of the 2018 Pitching Contest at their Winter Summit in Luxembourg. In this contest, Sensius competed with 44 startup and scaleup companies to present its proposition within the strict limitation of 3 minutes. After two preselection rounds, members of the audience voted Sensius to deliver the most convincing and comprehensive story from the 4 finalists.
Watch the short introduction to thermotherapy for head and neck cancer and Sensius
500 000 New patients worldwide get diagnosed with head and neck cancer annually. Treatment is very challenging. International biological research has proven that thermal therapy attacks cancer cells. The HyperCollar3D, developed by Erasmus MC, steers the heat to the tumor while avoiding sensitive organs. This therapy should be available worldwide - Sensius will deliver.